Emerging Trends and Key Drivers Fueling the Dry Eye Syndrome Market Growth forecast 2030: With a Striking CAGR of 4.21% – MarkNtel Advisors

How big is the Global Dry Eye Syndrome market?

According to MarkNtel Advisors study, The Global Dry Eye Syndrome Market size was valued at around USD 5.2 billion in 2023 and is estimated to grow at a CAGR of about 4.21% during the forecast period, i.e., 2024-30.

Get Your Hands On to the Free Sample Report (2024-30) – https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html

Global Dry Eye Syndrome Market Trend:

Advanced Drug Delivery Technologies – Advanced technologies like nanobiotechnology & microencapsulation for drug delivery are emerging as a new trend in the market. These technologies offer targeted drug delivery with precise & more effective results, improving the efficacy of the treatment. Additionally, these technologies allow sustained drug release, which reduces the frequency of drug dosage, enhances patient compliance, and has a formulation for longer shelf life. Furthermore, these drug-delivery technologies are also being explored for novel drugs with improved therapeutic profiles. For instance, in 2022, Alcon announced the launch of a complete preservative-free lubricant eye drop based on nanodroplet technology. Thus, the increasing adoption of advanced drug delivery technologies in the Dry Eye Syndrome Market is expected to drive innovation & growth during 2024-30.

Leading Companies in the Global Dry Eye Syndrome market:

  • Mitotech Pharma
  • ReGen Tree
  • Santen Pharmaceutical
  • HanAll Biopharma
  • Sun Pharma
  • Novaliq
  • Sylentis
  • Alcon
  • Horus pharma
  • Johnson& Johnson
  • Aldreya Therapeutics
  • Visufarma
  • Allergen
  • Prestige Consumer Health
  • Others

Explore Full Market Research Report – https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html

Global Dry Eye Syndrome Market Segmentation:

By Product

  • Artificial Tears- Market Size & Forecast 2019-2030, USD Million
  • Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
  • Cyclosporine– Market Size & Forecast 2019-2030, USD Million
  • Corticosteroid– Market Size & Forecast 2019-2030, USD Million
  • Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
  • Dissolvable– Market Size & Forecast 2019-2030, USD Million
  • Removable– Market Size & Forecast 2019-2030, USD Million
  • Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million

Anti-inflammatory drugs are among the most prevailing treatments for dry eye disease & have a high contribution in expanding the market size, hence driving the market growth.

By Disease Type

  • Aqueous Dry Eye – Market Size & Forecast 2019-2030, USD Million
  • Evaporative Dry Eye – Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

  • Offline- Market Size & Forecast 2019-2030, USD Million
  • Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
  • Hospital Pharmacies – Market Size & Forecast 2019-2030, USD Million
  • Online- Market Size & Forecast 2019-2030, USD Million

Regional/ Countries Insight:

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

North American region depicts considerable growth in the market, as the region captured the major share of the Dry Eye Syndrome Market owing to a large patient pool, increasing per capita healthcare expenditure, and soaring investment, merger, and acquisition of key players across the region.

Note: Should you require specific information beyond the current scope of the report, we are prepared to furnish it as part of our customization services.

To Get Customized Report, Sent Your Enquiry Here –  https://www.marknteladvisors.com/query/request-customization/dry-eye-disease-drugs-market.html

About MarkNtel Advisors:

MarkNtel Advisors is a leading consulting, data analytics, and market research company that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

For Media Inquiries:

please contact: Phone: +1 628 895 8081, +91 120 4278433

Email: [email protected]

Corporate Office: Office No.106, H-160, Sector 63, Noida, Uttar Pradesh – 201301, India